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Introduction
MAPKs function as the terminal components of three-tiered 
cascades of kinases comprised of a MAPK kinase kinase 
(MAP3K), MAPK kinase (MAP2K), and MAPK and are 
  important signal transducers in development, homeostasis, and 
disease (Chang and Karin, 2001). For example, the p38 sub-
family of MAPKs is involved in a wide variety of biological 
processes, including infl  ammation, stress responses, and cell 
differentiation (Zarubin and Han, 2005). The myriad roles of 
MAPK cascades indicate that the specifi  city of MAPK  activation 
and function must be regulated. One mechanism by which this 
occurs is via MAPK scaffold proteins, which are thought to 
provide (1) specifi  city between distinct MAPK subfamilies by 
assembling individual MAPK modules and (2) precise spatial 
and temporal regulation to MAPK signaling (Morrison and 
  Davis, 2003). How this latter function is accomplished is unclear, 
but it suggests that scaffold proteins may interact with cell-type 
specifi  c factors.
Differentiation of cells in the skeletal muscle lineage is 
coordinated by the family of myogenic bHLH factors (Myf5, 
MyoD, myogenin, and MRF4; Arnold and Braun, 2000).  During 
differentiation, these proteins work together with additional 
transcription factors, notably MEF2, to drive muscle-specifi  c 
gene expression and promote myoblast fusion into myofi  bers 
(Molkentin and Olson, 1996; Penn et al., 2004). Tight control of 
these transcription factors during myogenesis is required, and 
their activities are regulated by signal transduction pathways. 
Much evidence indicates that the p38α/β MAPK pathway plays 
an important role in myogenesis (Cuenda and Cohen, 1999; 
Zetser et al., 1999; Wu et al., 2000; de Angelis et al., 2005). 
p38α/β activity increases and persists in differentiating myo-
blasts, and differentiation is blocked by the p38α/β inhibitor 
SB203580. p38α/β phosphorylates several proteins involved in 
muscle-specifi  c gene expression, including MEF2 isoforms, the 
myogenic bHLH heterodimeric partner E47, the SWI–SNF 
complex subunit BAF60, and the RNA decay–promoting factor 
KH-type splicing regulatory protein (Wu et al., 2000; Simone 
et al., 2004; Briata et al., 2005; Lluis et al., 2005). MAPKs 
are generally activated in response to extracellular stimuli, and 
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many such cues that activate p38 during infl  ammatory and other 
responses have been identifi  ed (Dong et al., 2002). However, 
despite the attention p38α/β has received as a modulator of 
myogenesis, the signaling mechanisms by which it is activated 
during this process are largely unknown.
Cdo is a cell surface Ig superfamily member with a long 
intracellular region (Krauss et al., 2005). Cdo promotes myo-
genesis in vivo and in vitro; mice lacking Cdo display delayed 
skeletal muscle development, and primary myoblasts (satellite 
cells) obtained from such animals differentiate defectively in 
vitro, expressing reduced levels of muscle-specifi  c proteins 
and producing myotubes very ineffi  ciently (Cole et al., 2004). 
Cdo functions in myoblasts as a component of multiprotein 
  complexes that also include the closely related factor Boc, the 
Ig superfamily receptor neogenin and its ligand netrin-3, and the 
adhesion molecules N- and M-cadherin (Krauss et al., 2005). 
Experiments with myoblast cell lines and reporter assays in 
 fi broblasts indicate that one way Cdo promotes myogenesis is  to 
signal to posttranslationally activate myogenic bHLH factors in 
a fashion that requires its intracellular region (Cole et al., 2004; 
Krauss et al., 2005). We report that the Cdo intracellular region 
binds JLP, a scaffold protein for the p38α/β MAPK pathway 
(Lee et al., 2002; Kelkar et al., 2005). Cdo and JLP cooperate 
to activate p38α/β in transfectants, and   endogenous Cdo, JLP, 
and p38α/β form complexes during myoblast differentiation. 
Cdo
−/− satellite cells are defi  cient in their ability to activate 
p38α/β, and their defective differentiation phenotype is rescued 
by the expression of an activated form of a p38 MAP2K, MKK6. 
Thus, one way p38α/β is activated during myogenesis is through 
the interaction of a pathway-  specifi  c scaffolding module with a 
Cdo-containing cell surface complex.
Results and discussion
Cdo interacts with JLP
To identify proteins that interact with the Cdo intracellular 
region, a yeast two-hybrid screen was performed with a construct 
containing the Cdo transmembrane plus intracellular region as 
bait (Fig. 1 A). Several positive clones corresponded to a portion 
of JLP. The transmembrane plus intracellular region of a different 
Ig protein, Necl-2, was used as a control bait, and JLP did not 
 interact with Necl-2. Conversely, a Necl-2–binding protein, Pals2 
(Shingai et al., 2003), bound the Necl-2 bait but not the Cdo bait. 
JLP, JIP4, and SPAG9 are alternatively spliced products of a sin-
gle gene (Kelkar et al., 2005), and RT-PCR analysis suggested 
that JLP is the major product in C2C12 myoblasts (unpublished 
data). To assess whether Cdo and JLP interact in mammalian 
cells, lysates from Cdo
+/+ and Cdo
−/− satellite cells were immuno-
precipitated with antibodies to Cdo and blotted for the presence 
of JLP (Fig. 1 B). JLP was detected in immunoprecipitates from 
Cdo
+/+ but not Cdo
−/− lysates, indicating that Cdo was required 
to bring down JLP and that the antibody was specifi  c. In a recip-
rocal experiment, C2C12 myoblasts were transiently transfected 
with an expression vector encoding S epitope-tagged JLP or a 
Figure 1.  Cdo interacts with JLP. (A) Yeast transformed with the indicated vectors for Gal4 DNA-binding domain (BD) fused to the transmembrane (TM) 
plus intracellular regions (ICR) of Cdo or Necl-2 and Gal4 activation domain (AD) fused to a portion of JLP or Pals2 were plated on two-hybrid interaction-
dependent selective medium. (B) Lysates from satellite cells of the indicated Cdo genotype were immunoprecipitated (IP) and Western blotted (WB) as 
indicated. (C and D) Lysates of C2C12 (C) or COS (D) cells transfected with S-tagged JLP derivative or control (−) expression vectors were pulled down 
with anti-S beads and blotted as indicated for Cdo or S epitope. Asterisks in D indicate S-JLP bands of the predicted size. Numbers above lanes correspond 
to the JLP amino acids in individual fragments, which are shown schematically in E. (E) S-JLP derivatives from D and the yeast two-hybrid clone (GAD-JLP) 
are shown to identify the Cdo-binding region of JLP. The p38α/β-binding region of JLP is also shown.CDO, JLP, P38, AND MYOGENESIS • TAKAESU ET AL. 385
control vector, and lysates were precipitated with anti-S agarose 
(Fig. 1 C). Full-length endogenous Cdo was coprecipitated from 
the JLP transfectants but not the control transfectants. We con-
cluded that Cdo and JLP interact in myoblasts.
Coimmunoprecipitation experiments in COS cells were 
then used to identify regions of JLP and Cdo involved in  binding. 
A series of S-tagged fragments of JLP were coexpressed with 
Cdo and lysates pulled down with anti-S agarose (Fig. 1 D). Only 
a fragment encoding amino acids 465–1,008 coprecipitated Cdo; 
because a positive yeast two-hybrid clone contained JLP amino 
acids 317–647 (Fig. 1 A), the major Cdo-binding region of 
JLP resides between amino acids 465–647. p38α/β binds to two 
sites within JLP (amino acids 1–110 and 160–209; Lee et al., 
2002), neither of which overlaps the Cdo-binding region (Fig. 
1 E), suggesting that Cdo, JLP, and p38 could form a ternary 
complex. An analogous experiment was performed with Cdo 
deletion mutants that lack portions of the intracellular region. 
Loss of JLP binding was seen in each case (Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200608031/DC1). It is 
possible that multiple regions of the Cdo cytoplasmic domain 
are required to provide structural integrity suffi  cient for JLP 
binding or that the Cdo deletion mutants may not be targeted to 
an appropriate subcellular compartment for interaction.
Cdo-p38 signaling
To begin to determine whether Cdo–JLP interaction has a 
  positive effect on p38α/β activity, transfections in heterologous 
systems were used. 293T cells were transfected with a vector 
encoding T7-tagged p38α and various combinations of other 
expression vectors, and lysates were blotted with antibodies to 
the dually phosphorylated (active) form of p38α/β (pp38α/β; 
Fig. 2 A). The expression of p38α alone resulted in very low 
levels of pp38α, but the coexpression of ASK1 (a p38 MAP3K) 
produced abundant pp38α. The expression of Cdo increased the 
levels of pp38α above that seen with p38α alone, and this was fur-
ther increased in a dose-dependent manner by the coexpression of 
JLP. The expression of JLP without Cdo was less effective. Cdo–
JLP interaction was also tested with a MyoD-dependent reporter 
gene assay in fi  broblasts, in which an activated form of the p38 
MAP2K, MKK6 (MKK6EE), enhances MyoD activity (Wu et al., 
2000). Although the cotransfection of Cdo or JLP separately 
each increased MyoD-dependent reporter activity above what 
p38α alone produced, cotransfection of the two   together pro-
duced  80% above what would be expected from a purely ad-
ditive response (Fig. 2 B). Although the effects of Cdo and JLP 
coexpression on p38α activity in these heterologous systems 
are relatively modest, they are clearly stimulatory.
We next asked whether endogenous Cdo, JLP, and p38α/β 
could be found in complexes during myogenesis. C2C12 cells 
were harvested while proliferating in growth medium (GM), 
at the time of transfer to differentiation medium (DM), and 
48 h after transfer, when they were differentiating. Lysates 
were immunoprecipitated with Cdo antibodies and blotted for 
JLP, p38α/β, and Cdo; whole lysates were also probed for the 
Figure 2.  Cdo, JLP, and p38𝗂/𝗃 interact during 
myogenesis. (A) 293T cells were transfected with the 
indicated expression vectors and lysates and were 
Western blotted as indicated. (B) 10T1/2 cells were 
transfected with the indicated expression vectors plus 
4Rtk-luc reporter and, as a control, CMV-lacZ reporter. 
Luciferase activity was normalized to β-galactosidase 
activity, and data are reported as the fold induction 
over the activity of transfectants receiving expression 
vectors lacking inserts (−). Values are means of dupli-
cate determinations ± SD (error bars). The experi
ment was performed three times with similar results. 
(C) C2C12 cells were cultured in GM (−), at the time 
of shift to DM (0), or 48 h later, and lysates were 
immunoprecipitated and Western blotted as indicated. 
(D) C2C12 cells were transfected with control (−) or 
JLP RNAi expression vectors, transfectants were sorted, 
and lysates were immunoprecipitated and Western 
blotted as indicated. (E) Cells from D were cultured in 
DM, ﬁ  xed, and stained for the expression of MHC to 
reveal myotube formation.JCB • VOLUME 175 • NUMBER 3 • 2006  386
expression of total p38, JLP, pp38α/β, and the differentiation mar  -
kers myogenin and myosin heavy chain (MHC; Fig. 2 C). JLP and 
p38α/β coprecipitated with Cdo only when the cells were actively 
differentiating despite the fact that total levels of all three proteins 
were unchanged in the various conditions examined. Further-
more, the formation of this complex correlated with pp38α/β 
production. It is likely that p38α/β coprecipitates with Cdo via 
binding to JLP, which interacts with Cdo, as p38α and Cdo did 
not interact in the yeast two-hybrid system (Fig. S2, available 
at http://www.jcb.org/cgi/content/full/jcb.200608031/DC1). To 
  address this notion more directly, an RNAi approach was used. 
The pSilencer vector containing a sequence corresponding to 
mouse Jlp or an irrelevant sequence (as a control) was cotrans-
fected into C2C12 cells with a GFP expression   vector, and the 
cultures were sorted for the presence of GFP. Sorted cultures 
were replated and subsequently transferred into DM for 48 h, at 
which point whole lysates and lysates immunoprecipitated with 
Cdo antibodies were blotted for JLP, p38α/β, and Cdo (Fig. 
2 D). RNAi-mediated knockdown of JLP led to a substantial 
  decrease in the amount of p38α/β that coprecipitated with Cdo 
even though total levels of p38 were unaffected. Collectively, 
these results argue in favor of a model in which Cdo binds to 
JLP and JLP binds to p38α/β. Importantly, C2C12 cells that ex-
pressed RNAi to Jlp differentiated less effi  ciently than control 
transfectants as measured by myotube formation (fusion indices: 
control cells = 61.7 ± 4.2% and Jlp RNAi-expressing cells = 
31.3 ± 5.9%; Fig. 2 E).
To assess the effect of Cdo loss on p38α/β activity during 
myogenesis, pp38α/β levels were examined in Cdo
+/+ and 
Cdo
−/− satellite cells in GM and DM (Fig. 3 A). Unlike C2C12 
cells, satellite cells must be cultured in basic FGF to remain in 
a proliferative nondifferentiated state, and this is associated 
with production of a pool of pp38α/β that is thought to target 
substrates distinct from those involved in differentiation (Jones 
et al., 2005). Both Cdo
+/+ and Cdo
−/− satellite cells produced 
roughly similar amounts of pp38α/β when cultured in GM/ 
basic FGF. As expected, Cdo
+/+ cells increased their relative 
pp38α/β levels when cultured in DM; in contrast, Cdo
−/− 
cells failed to increase or even maintain pp38α/β levels in DM, 
  resulting in an approximately sixfold lower level of pp38α/β 
than Cdo
+/+ cells.
If this lack of differentiation-associated pp38α/β was 
causally involved in the defective myogenic phenotype of Cdo
−/− 
cells, it would be predicted that the restoration of p38α/β activ-
ity at a point downstream of Cdo would rescue the differentia-
tion of these cells. To test this hypothesis, Cdo
+/+ and Cdo
−/− 
cells were infected with recombinant adenoviruses encoding 
  either MKK6EE or, as a control, GFP. As seen with uninfected 
cultures, Cdo
+/+ cells infected with the GFP virus had higher 
levels of pp38α/β than did GFP vector–infected Cdo
−/− cells; 
however, infection with the MKK6EE virus drove production of 
abundant pp38α/β in both cell types without altering total p38α/β 
levels (Fig. 3 B). These cultures were then scored for the expres-
sion of MHC and production of multinucleated myotubes when 
cultured under differentiation conditions for 72 h (Fig. 3, C–E). 
The percentages of GFP vector–infected Cdo
+/+ cells that were 
MHC
+ versus MHC
− was  80/20, whereas the   percentages of 
similarly infected Cdo
−/− cells were  50/50. The expression of 
MKK6EE in Cdo
−/− cells restored the 80/20 percent ratio of 
MHC
+ versus MHC
− cells seen in Cdo
+/+ cells but had little 
 effect  on  Cdo
+/+ cells (Fig. 3 D). Likewise, GFP vector–infected 
Cdo
+/+ cells formed elongated myotubes and had a fusion index 
more than fourfold higher than Cdo
−/− cells, which failed to 
elongate (Fig. 3, C and E). Infection of Cdo
−/− cells with the 
MKK6EE virus led to the production of elongated myotubes by 
these cells and raised their fusion index to a level similar to 
that seen with Cdo
+/+ cells, which were much more modestly 
  affected by the expression of MKK6EE (Fig. 3, C and E). 
Similar results were obtained in C2C12 myoblasts. 
Differentiation of these cells was inhibited by the expression of 
RNAi to Cdo, but production of MHC and multinucleated cells 
Figure 3.  MKK6EE rescues the differentiation-defective phenotype of 
Cdo
−/− satellite cells. (A, top) Lysates from satellite cells of the indicated Cdo 
genotype cultured in GM or DM were Western blotted as indicated. (bottom) 
The image was quantiﬁ   ed by densitometry with the pp38α/β signal 
  normalized to the p38α/β signal. Units are arbitrary with Cdo
+/+ cells in 
GM set to 1. The experiment was repeated three times with similar results. 
(B) Lysates from satellite cells of the indicated Cdo genotype infected with 
GFP- or HA-tagged MKK6EE-expressing adenoviruses were placed into 
differentiation-inducing conditions and Western blotted as indicated. (C) Cells 
as in B were stained for MHC expression (red) and with DAPI to stain nuclei 
(blue). (D) Quantiﬁ  cation of the percentage of nuclei in MHC
+ and MHC
− 
cells in cultures of the indicated types. (E) Quantiﬁ  cation of the percentage 
of nuclei in multinucleated cells (fusion index) in cultures of the indicated 
types. The experiment was repeated three times with similar results. (D and E) 
Values are means of triplicate determinations ± SD (error bars).CDO, JLP, P38, AND MYOGENESIS • TAKAESU ET AL. 387
was restored by the coexpression of MKK6EE (Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200608031/DC1). 
It is concluded that the expression of MKK6EE specifi  cally 
  rescues the defects in myogenic differentiation caused by Cdo 
defi  ciency, presumably via restoration of p38α/β activity.
Activation of p38𝗂/𝗃 during myogenesis
p38α/β MAPK is established as a promyogenic kinase, but the 
mechanisms by which it is activated during differentiation are 
not well understood. Certain soluble signaling factors,  including 
ATP and amphoterin, stimulate p38α/β activity and enhance 
myogenesis when added exogenously to cultured myoblasts; 
likewise, the expression of a dominant-negative amphoterin 
receptor blocks production of pp38α/β and differentiation (Ryten 
et al., 2002; Sorci et al., 2004). Additionally, MyoD activity 
stimulates a feed-forward pathway that involves activation of 
p38 via induction of target genes (Penn et al., 2004). However, 
in general, the signaling mechanisms underlying p38α/β activa-
tion by these factors are not clear nor are they confi  rmed by 
  genetic loss of function data.
The results described here reveal a novel mechanism 
of p38α/β activation during myogenesis: the interaction of 
JLP, a p38α/β MAPK scaffold protein, with Cdo, which is a 
  component of multiprotein cell surface complexes comprised 
of promyogenic signaling receptors and adhesion molecules 
(Fig. 4). The binding of a MAPK scaffold protein to the intra-
cellular region of a transmembrane receptor protein is unusual; 
furthermore, this mechanism is distinct from other known 
receptor-mediated signaling mechanisms, such as intrinsic en-
zyme activity (e.g., receptor tyrosine kinases) or direct coupling 
to nonreceptor tyrosine kinases (e.g., cytokine receptors). JIP3, 
which is structurally related to JLP, binds the cytoplasmic tail 
of Toll-like receptor 4 (Matsuguchi et al., 2003), suggesting 
that direct interaction with transmembrane receptors may be a 
  feature of this class of scaffold protein. It is anticipated that 
in its role as a scaffold (Lee et al., 2002; Kelkar et al., 2005), 
JLP brings additional components of the pathway, such as 
MAP3Ks and MAP2Ks, to these complexes. Furthermore, the 
interaction of a pathway-specifi  c scaffolding module with Cdo-
containing cell surface complexes may allow the coordination 
of additional signals required for p38α/β activity via the actions 
of other membrane components of such complexes (e.g., regu-
lation of small GTPases by cadherins; Charrasse et al., 2002). 
Cdo is also expressed in and promotes the differentiation of 
neuronal precursors (Zhang et al., 2006b), and similar signaling 
mechanisms may be involved in myogenesis and neurogenesis. 
Assembly at sites of cell–cell contact of higher order structures 
comprised of multiprotein cell surface complexes and intra-
cellular signaling modules is an appealing mechanism for coordi-
nating changes in gene expression and cell morphology during 
cell differentiation in general.
Materials and methods
Yeast two-hybrid screen
A cDNA encoding the transmembrane and intracellular regions of mouse 
Cdo (amino acids 948–1,250) was fused in frame to the Gal4 DNA-
  binding domain in the pGBDU-C1 vector. The yeast strain PJ69-4A was 
  sequentially transformed with this vector and a library containing mouse 
embryo cDNAs fused to the Gal4 activation domain via lithium acetate. 
Approximately 4.2 × 10
5 transformants were obtained and screened as 
described previously (James et al., 1996). Four identical clones encoding 
amino acids 317–647 of JLP were isolated.
Cell culture
C2C12, 10T1/2, 293T, COS-7, and satellite cells isolated from Cdo
+/+ 
and Cdo
−/− mice were cultured as described previously (Cole et al., 2004; 
Kang et al., 2004). To induce differentiation, C2C12 and satellite cells 
were transferred into medium containing 2% horse serum or 5% FBS, 
  respectively. Quantiﬁ   cation of myotube formation was performed as 
  described previously (Kang et al., 2004).
For RNAi studies shown in Fig. 2, the Jlp sequence 5′-A  G  A  T  G  C  G  T  C-
T  A  T  G  A  A  G  C  T  G  -3′ was inserted into the pSilencer 2.0-U6 vector (Ambion). 
pSilencer 2.0-U6 expressing an irrelevant sequence (Ambion) was used as 
a control. These vectors were transfected along with a GFP expression vector. 
Cells were sorted for the presence of GFP and analyzed by coimmuno-
precipitation and Western blotting as described in the next paragraph and 
for the ability to form myotubes. RNAi-mediated knockdown of Cdo was 
as described previously (Zhang et al., 2006a), and transient assay of its 
effects on C2C12 differentiation was performed as described previously 
(Kang et al., 2004). Replication-deﬁ  cient adenoviruses encoding GFP or 
HA-tagged MKK6EE were provided by M. Meseck (Mount Sinai School of 
Medicine, New York, NY) and L. Puri (Burnham Institute, La Jolla, CA; 
Simone et al., 2004), respectively, and ampliﬁ  ed in 293T cells. Satellite 
cell cultures were infected at an MOI of 50 and assessed for the expression 
of MKK6EE, pp38α/β, and MHC and for myotube formation.
Protein and reporter assays
Western blot analyses were performed as described previously by Kang 
et al. (2004). For immunoprecipitations, cells were lysed in extraction buffer 
(20 mM Hepes, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 10 mM NaF, 
Figure 4.  Model of Cdo–JLP interaction during myogenic 
differentiation. A complex of Cdo and its partner proteins 
positively regulates myogenic differentiation (Krauss et al., 
2005). One way this occurs is via the interaction of JLP with 
the Cdo cytoplasmic tail. JLP is, in turn, bound to p38α/β. 
This interaction facilitates p38 activation during differentia-
tion and is important for Cdo’s effects in myogenesis.JCB • VOLUME 175 • NUMBER 3 • 2006  388
2 mM DTT, 1 mM Na3VO4, and 0.5% Triton X-100 supplemented with 
1 tablet/40 ml of Complete protease inhibitor cocktail [Roche]). 2 mg of 
whole cell extract from each sample was precleared with protein G–
Sepharose (GE Healthcare) conjugated with 2 μg of normal rabbit IgG 
(Santa Cruz Biotechnology, Inc.) for 1 h at 4°C followed by immunoprecipi-
tation with 2 μg anti-Cdo antibody for 2 h at 4°C. Immunocomplexes were 
washed three times with and suspended in extraction buffer, and samples 
were analyzed by Western blotting. For pull-down experiments, 4 × 10
5 
cells were seeded onto 100-mm plates 1 d before transfection with plas-
mids encoding a series of S-tagged JLP proteins (Lee et al., 2002). 2 d after 
transfection, cells were harvested and lysed in extraction buffer. Whole 
cell extracts were incubated with 20 μl of 50% slurry S-protein agarose 
beads (Novagen) for 3.5 h at 4°C. Beads were washed three times with 
and suspended in extraction buffer, and samples were analyzed by 
Western blotting.
Antibodies used in this study are as follows: anti-Cdo (Zymed 
  Laboratories), anti-JLP (Abcam), anti-p38α/β (Sigma-Aldrich), anti-pp38α/β 
(Cell Signaling Technology), anti-T7 (Novagen), anti-S probe (Santa Cruz 
Biotechnology, Inc.), anti-MHC (MF-20; Developmental Studies Hybridoma 
Bank), and antimyogenin (Santa Cruz Biotechnology, Inc.).
For reporter assays, 3 × 10
5 10T1/2 cells were seeded onto indi-
vidual wells of a six-well plate 1 d before transfection with FuGene6 
(Roche). For each well, 200 ng 4RTK-luc and, as an internal control, 100 ng 
CMV-lacZ plasmids were transfected along with expression vectors for 
MyoD (50 ng), E47 (10 ng), p38α (100 ng), Cdo (200 ng), and JLP (400 ng) 
as indicated in Fig. 2 B. Cells were incubated for 48 h after transfection 
and harvested to determine luciferase and β-galactosidase activity as 
described previously (Cole et al., 2004; Zhang et al., 2006a).
Microscopy
Cultures were processed as described previously (Kang et al., 2004) and 
examined on a phase-contrast microscope (Eclipse TS100; Nikon) with 
plan Fluor 10× NA 0.3 and 20× NA 0.45 objectives (Nikon) at room 
temperature. Images were captured with a camera (model 2.2.1 Spot RT 
Color; Diagnostic Instruments) using Spot software (version 3.5.9; Diag-
nostic Instruments) and Photoshop 7.0 (Adobe).
Online supplemental material
Fig. S1 shows that Cdo deletion mutants do not bind to JLP, and Fig. S2 
shows that p38α does not bind to Cdo. Fig. S3 shows that MKK6EE 
rescues the block to C2C12 cell differentiation imposed by RNAi to 
Cdo. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200608031/DC1.
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